Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis

Brain

Volumn 122, Issue 2, 1999, Pages 291-301

  Edwards, S G M ^a   Gong, Q Y ^c   Liu, C ^a   Zvartau, M E ^a   Jaspan, T ^b   Roberts, N ^c   Blumhardt, Lance D ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NONE

Author keywords

Atrophy; Infratentorial; MPRAGE; MRI; Multiple sclerosis

Indexed keywords

MYELIN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBELLUM TENTORIUM; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISABILITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE; STEREOLOGY;

ACTIVITIES OF DAILY LIVING; ADULT; ATROPHY; BRAIN STEM; CEREBELLUM; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; SPINAL CORD;

EID: 0032955860     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.2.291     Document Type: Article

References (82)

1. Adams RD, Kubik CS. The morbid anatomy of the demyelinative diseases. Am J Med 1952; 12: 510-46.
2. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994; 36: 76-82.
3. Aylward E, Reiss A. Area and volume measurements of posterior fossa structures in MRI. J Psychiatr Res 1991; 25: 159-68.
4. Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW, et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol 1990; 47: 19-26.
5. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
6. Brainin M, Goldenberg G, Ahlers C, Reisner T, Neuhold A, Deecke L. Structural brain correlates of anterograde memory deficits in multiple sclerosis. J Neurol 1988; 235: 362-5.
7. Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence - initial experience in the brain. Radiology 1992; 182: 769-75.
8. Chida K, Goto N, Kamikura I, Takasu T. Quantitative evaluation of pontine atrophy using computer tomography. Neuroradiology 1989; 31: 13-5.
9. Clark CM, James G, Li D, Oger J, Paty D, Klonoff GH. Ventricular size, cognitive function and depression in patients with multiple sclerosis. Can J Neurol Sci 1992; 19: 352-6.
10. Comi G, Filippi M, Martinelli V, Sirabian G, Visciani A, Campi A, et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci 1993; 115 Suppl: S66-73.
11. Cruz-Orive LM, Roberts N. Unbiased volume estimation with coaxial sections: an application to the human bladder. J Microsc 1993; 170: 25-33.
12. Daniels DL, Haughton VM, Naidich TP. Cranial and spinal magnetic resonance imaging. An atlas and guide. New York: Raven Press; 1987.
13. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss [published erratum appears in Brain 1996; 119: 1415]. Brain 1995; 118: 1583-92.
14. Davie CA, Barker GJ, Thompson AJ, Tofts PS, McDonald WI. Miller DH. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63: 736-42.
15. Dietemann JL, Beigelman C, Rumbach CL, Vouge M, Tajahmady T, Faubert C, et al. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology 1988; 30: 478-80.
16. Edwards SG, Roberts N, Blumhardt LD. Supratentorial white matter volumes on magnetic resonance images correlate with cognitive performance in multiple sclerosis (MS) [abstract]. J Neurol Neurosurg Psychiatry 1997; 63: 692-3.
17. Escalona PR, McDonald WM, Doraiswamy PM, Boyko OB, Husain MM. Figiel GS, et al. In vivo stereological assessment of human cerebellar volume: effects of gender and age. AJRN Am J Neuroradiol 1991; 12: 927-9.
18. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
19. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995a; 45: 255-60.
20. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995b; 45: 478-82.
21. Filippi M, Campi A, Colombo B, Pereira C, Martinelli V, Barrati C, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996a; 243: 502-5.
22. Filippi M, Yousry T, Horsfield MA, Alkadhi H, Rovaris M, Campi A, et al. A high resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996b; 40: 91-7.
23. Francis DA, Bain P, Swan AV, Hughes RA. An assessment of disability rating scales used in multiple sclerosis. Arch Neurol 1991; 48: 299-301.
24. Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/ progressive multiple sclerosis. Neurology 1988; 38: 1826-9.
25. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A. et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36: 62-7.
26. Gong QY, Edwards SGM, Roberts N, Whitehouse GH, Evans S, Jaspan T, et al. Evaluation of 3D MPRAGE in multiple sclerosis [abstract]. Br. J Radiol 1996; 69 Suppl: 280.
27. Greenfield JG, King LS. Observations on the histopathology of the cerebral lesions in disseminated sclerosis. Brain 1936; 59: 445-58.
28. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147: 229-63.
29. Gundersen HJ, Osterby R. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J Microsc 1981; 121: 65-73.
30. Huber SJ, Paulson GW, Shuttleworth EC, Chakeres D, Clapp LE, Pakalnis A, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 1987; 44: 732-6.
31. Isaac C, Li DK, Genton M, Jardine C, Grochowski E, Palmer M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988; 38: 1511-5.
32. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-7.
33. Kidd D, Thorpe JW, Kendall BE, Barker GJ, Miller DH, McDonald WI, et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 15-9.
34. Kidd D, Barker GJ. Tofts PS, Gass A, Thompson AJ, McDonald WI, et al. The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J Neurol 1997; 244: 125-30.
35. Koopmans RA, Li DK, Grochowski E, Cutler PJ, Paly DW. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989; 25: 74-81.
36. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
37. Laissy JP, Patrux B, Duchateau C, Hannequin D, Hugonet P, AitYahia H. et al. Mid-sagittal MR measurements of the corpus callosum in healthy subjects and diseased patients: a prospective survey. Am J Neuroradiol 1993; 14: 145-54.
38. Loizou LA, Rolfe EB, Hewazy H. Cranial computed tomography in the diagnostic evaluation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1982; 45: 905-12.
39. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996a; 119: 2009-19.
40. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996b; 119: 701-8.
41. Lumsden CE. An outline of the pathology of multiple sclerosis. In: McAlpine D, Lumsden CE, Acheson ED, editors. Multiple sclerosis. A reappraisal. 2nd edn. Edinburgh: Churchill Livingstone; 1972. p. 314-21.
42. Madrid RE, Wisniewski HM. Axonal degeneration in demyelinating disorders. J Neurocytol 1977; 6: 103-17.
43. Matheron G. The theory of regionalised variables and its application. In: Les cahiers du centre de morpholgie mathematique de Fontainbleu no. 5. Fontainbleu: Ecole National Superieur des Mines de Paris; 1971.
44. Maurelli M, Marchioni E, Cerretano R, Bosone D, Bergamaschi R, Citterio A, et al. Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships. Acta Neurol Scand 1992; 86: 124-8.
45. Mayhew TM, Olsen DR. Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle. J Anat 1991; 178: 133-44.
46. Noseworthy JH. Clinical scoring methods for multiple sclerosis. [Review]. Ann Neurol 1994; 36 Suppl: S80-5.
47. Noseworthy JH, Paty DW, Ebers GC. Neuroimaging in multiple sclerosis. Neurol Clin 1984; 2: 759-77.
48. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial [see comments]. Neurology 1990; 40: 971-5. Comment in: Neurology 1991; 41: 332.
49. Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial [see comments]. Neurology 1990; 40: 971-5. Comment in: Neurology 1991; 41: 332.
50. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978; 4: 151-62.
51. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
52. Pache JC, Roberts N, Vock P, Zimmermann A, Cruz-Orive LM. Vertical LM sectioning and parallel CT scanning designs for stereology: application to human lung. J Microsc 1993; 170: 9-24.
53. Pakkenberg B, Boesen J, Albeck M, Gjerris F. Unbiased and efficient estimation of total ventricular volume of the brain obtained from CT-scans by a stereological method. Neuroradiology 1989; 31: 413-7.
54. Paty DW, Li DK. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in: Neurology 1993; 43: 641-3.
55. Paty DW, Li DK. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in: Neurology 1993; 43: 641-3.
56. Pelletier J, Habib M, Lyon-Caen O, Salamon G, Poncet M, Khalil R. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol 1993; 50: 1077-82.
57. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
58. Pozzilli C, Passafiume D, Bemardi S, Pantano P. Incoccia C, Bastaniello S, et al. SPECT, MRI and cognitive functions in multiple sclerosis. J Neurol Neurosurg Psychiatry 1991; 54: 110-5.
59. Prineas JW. Pathology of multiple sclerosis. In: Cook SD, editor. Handbook of multiple sclerosis. 2nd edn. New York: Marcel Dekker; 1996, p. 223-55.
60. Prineas JW, Connell F. The fine structure of chronically active multiple sclerosis plaques. Neurology 1978; 28: 68-75.
61. Raine CS. Demyelinating lesions. In: Davis PL, Robertson DM, editors. Textbook of neuropathology, Baltimore (MD): Williams and Wilkins; 1985, p. 553-620.
62. Raine CS. The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman and Hall; 1997a, p. 243-86.
63. Raine CS. The neuropathology of multiple sclerosis. In: Raine CS, McFarland HF. Tourtellotte WW, editors. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman and Hall; 1997b, p. 151-71.
64. Raininko R. Autti T, Vanhanen S, Ylikoski A, Erkinjuntti T, Santavuori P. The normal brain stem from infancy to old age: a morphometric MRI study. Neuroradiology 1994; 36: 364-8.
65. Rao SM, Glatt S, Hammeke TA, McQuillen MP, Khatri BO, Rhodes AM, et al. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985; 42: 678-82.
66. Ruo SM, Bernardin L, Leo GJ, Ellington L, Ryan SB, Burg LS, Cerebral disconnection in multiple sclerosis: relationship to atrophy of the corpus callosum. Arch Neurol 1989a; 46: 918-20.
67. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989b; 39: 161-6.
68. Regeur L, Pakkenberg B. Optimizing sampling designs for volume measurements of components of human brain using a stereological method. J Microsc 1989; 155: 113-21.
69. Roberts N, Cruz-Orive LM, Reid NM, Brodie DA, Bourne M, Edwards RH. Unbiased estimation of human body composition by the Cavalieri method using magnetic resonance imaging. J Microsc 1993; 171: 239-53.
70. Roberts N, Barbosa S, Blumhardt LD, Karowski RA, Edwards RH. Stereological estimation of the total volume of MR visible brain lesions in patients with multiple sclerosis. MAGMA 1994; 2: 375-8.
71. Shah M, Ross JS, Van Dyke C, Rudick RA, Goodkin DE, Obuchowski N, et al. Volume T1-weighted gradient echo MRI in multiple sclerosis patients. J Comput Assist Tomogr 1992; 16: 731-6.
72. Simon JH, Schiffer RB, Rudick RA, Herndon RM. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. AJRN Am J Neuroradiol 1987; 8: 599-604.
73. Sipe JC, Knobler RL, Barheny SL, Rice GP, Panitch HS, Oldstone MB. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 1984; 34: 1368-72.
74. Swirsky-Sacchetti T, Mitchell D, Knobler RL, Gonzales C, Seward J, Field HI, et al. Analysis and correlation of neuropsychological deficits with structural brain lesions in patients with multiple sclerosis [abstract]. Neurology 1991; 41 Suppl 1: 145.
75. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study [see comments]. Br Med J 1990; 300: 631-4. Comment in Br Med J 1990; 300: 1272.
76. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study [see comments]. Br Med J 1990; 300: 631-4. Comment in Br Med J 1990; 300: 1272.
77. Thorpe JW, Barker GJ, Jones SJ, Moseley I, Losseff N, MacManus DG, et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry 1995; 59: 487-92.
78. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N Engl J Med 1998; 338: 278-85. Comment in: N Engl J Med 1998; 338: 323-5.
79. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis [see comments]. N Engl J Med 1998; 338: 278-85. Comment in: N Engl J Med 1998; 338: 323-5.
80. Wiebe S, Lee DH, Karlik SJ, Hopkins M, Vandervoort MK, Wong CJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992; 32: 643-50.
81. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988; 38: 1793-8.
82. Zimmerman HM, Netsky MG. The pathology of multiple sclerosis. Res Publ Assoc Res Nerv Ment Dis 1950; 28: 271-312.